Medications with CGRP inhibitors in chronic migraine under conditions in the basic package

Three new medicines (CGRP inhibitors) for the treatment of chronic migraine can be reimbursed from the basic package. This is written by the National Health Care Institute in an advisory report to the Minister for Medical Care. The Zorginstituut attaches conditions to the reimbursement: only patients with chronic migraine who do not respond to 2 other treatment methods that are already reimbursed are eligible.

Read the source article at archynewsy.com
2021-09-21 18:15:30